Trevi Therapeutics (TRVI) Non Operating Income (2018 - 2022)

Trevi Therapeutics' Non Operating Income history runs 8 years deep, the most recent figure standing at $1.9 million for Q4 2025.

• In Q4 2025, Non Operating Income rose 123.7% year-over-year to $1.9 million; the TTM figure through Dec 2025 stood at $6.2 million (up 73.9% YoY), while the FY2025 annual figure was $6.5 million, up 81.55% from the prior year.
• Non Operating Income for Q4 2025 stood at $1.9 million, down from $2.1 million in the prior quarter.
• The five-year high for Non Operating Income was $2.2 million in Q4 2022, with the low at -$297000.0 in Q1 2021.
• The 5-year median for Non Operating Income is $996000.0 (2024), against an average of $884105.3.
• The sharpest annual moves came in 2022 and 2023: Non Operating Income tumbled 11900.0% in 2022, then surged 28775.0% in 2023.
• Trevi Therapeutics' Non Operating Income stood at $1.2 million in 2021, then jumped by 73.35% to $2.2 million in 2022, then tumbled by 47.52% to $1.1 million in 2023, then dropped by 25.31% to $844000.0 in 2024, then soared by 123.7% to $1.9 million in 2025.
• Business Quant data shows TRVI's Non Operating Income at $1.9 million in Q4 2025, $2.1 million in Q3 2025, and $1.4 million in Q2 2025.